Cara Therapeutics | CARA - Despesa De Juros Sobre A Dívida





Despesa De Juros Sobre A Dívida Alterar Data
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Cara Therapeutics -89.64M 128.67M 2025-12
Cassava Sciences USD 100.06M 99.31M 2026-09
Chugai Pharma JPY 95M 260M 2025-12
Cipla INR 167.4M 2.9M 2026-09
Compugen USD 1.84M 485K 2026-06
CSL USD 215M 111M 2025-12
Grifols EUR 156.07M 31.46M 2025-09
Halozyme Therapeutics USD 6.04M 457K 2026-09
J&J USD 43M 25M 2026-03
Neurocrine Biosciences USD 300K 2.6M 2026-09
Pacira USD 112.4M 108.78M 2026-09
Pfizer USD 662M 5M 2026-09
RedHill Biopharma USD 89.8K 31.69M 2024-06
Supernus Pharmaceuticals USD 718K 1.6M 2026-09
Vanda Pharmaceuticals -1.37B 1.97B 2025-12